Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsMetabolic & Weight LossSubcutaneous

Leptin

Also known as: OB protein, Obese gene product

Adipokine hormone that regulates energy expenditure, appetite, and immune function through hypothalamic signaling.

Research Status

Clinical Trials

Clinical trials

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Regulates appetite and energy expenditure
Improves insulin sensitivity and glucose metabolism
Enhances immune function and inflammatory response
Supports reproductive and thyroid hormone signaling
May improve metabolic rate in leptin-deficient states
Supports bone metabolism and skeletal health

Side Effects

Injection site reactions
CommonMild

Redness, mild swelling, or bruising at the injection site typically resolves within 24-48 hours. Minimize by rotating injection sites, allowing solution to reach room temperature, and using proper injection technique. Apply ice if needed.

Lipodystrophy (localized fat loss or thickening)
UncommonModerate

Repeated injections at the same site can cause localized fat atrophy or hypertrophy. Prevent by systematically rotating injection sites and maintaining at least 1 inch between consecutive injection points. This is reversible if site rotation is implemented.

Headache
UncommonMild

Mild headaches have been reported in clinical trials, typically occurring within hours of injection and resolving within 24 hours. May be related to rapid changes in metabolic signaling.

Nausea or mild gastrointestinal discomfort
UncommonMild

Transient nausea or mild GI symptoms may occur, particularly with higher doses. Usually self-resolving within 24 hours. Taking the injection in the evening may reduce daytime symptoms.

Appetite suppression or early satiety
CommonMild

This is the intended pharmacological effect in research contexts. Ensure adequate caloric and nutrient intake to prevent unintended weight loss or nutritional deficiency.

Increased energy or mild insomnia
UncommonMild

Leptin increases metabolic rate and energy expenditure; some users report increased alertness or difficulty sleeping if injected too late in the day. Consider morning or early afternoon dosing if this occurs.

Immune activation or mild fever
RareMild

Leptin enhances immune function; rarely, users may experience mild fever or transient immune activation symptoms. This is typically self-limiting and reflects the peptide's immunomodulatory effects.

Hypoglycemia risk (in insulin-treated patients)
RareSerious

Leptin improves insulin sensitivity; patients on insulin therapy may experience hypoglycemia. Blood glucose monitoring is essential. Consult a healthcare provider before using leptin if taking insulin or glucose-lowering medications.

Allergic reaction (rare)
RareSerious

Severe allergic reactions including anaphylaxis are rare but possible. Symptoms include difficulty breathing, swelling of face/throat, or severe rash. Seek immediate medical attention if these occur. Discontinue use and do not re-inject.

Infection at injection site
RareSerious

Poor injection technique or non-sterile conditions can lead to bacterial infection. Signs include increasing redness, warmth, pus, or systemic fever. Seek medical evaluation if infection is suspected.

Dosing Reference

ParameterValue
Dose range0.1-1 mg
Frequency1-2x daily
TimingTypically administered in the evening or split between morning and evening for circadian alignment
RouteSubcutaneous

Dosing varies significantly based on body weight and leptin sensitivity status. Research protocols typically use 0.1–1 mg per injection. For research purposes only. Efficacy depends on leptin receptor function; leptin resistance may require higher doses or adjunctive therapies.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Molecular weight16000
Half-life24-25 hours (endogenous); recombinant leptin half-life approximately 4-6 hours in circulation
SequenceMVHFLSLLLTFFSAYSRQ LDGLLEYLLASLQKRKQR TGLGFLLKQTLVTMETSA LPLLNDQWLIVKQTLVTM ETSALPLLNDQWLIVKQT LVTMETSALPLLNDQWLI VKQTLVTMETSALPLLND QWLIVKQTLVTMETSALP LLNDQWLIVKQTLVTMET SALPLLNDQWLIVKQTLV TMETSALPLLNDQWLIVK QTLVTMETSALPLLNDQW LIVKQTLVTMETSALPLL NDQWLIVKQTLVTMETSALP

Leptin is an adipokine hormone produced primarily by adipose tissue that acts on leptin receptors (OB-R) in the hypothalamus to regulate energy homeostasis, appetite suppression, and metabolic rate. It signals the brain about energy stores, promoting satiety and increasing energy expenditure while simultaneously regulating immune function, reproductive hormones, and thyroid signaling through multiple downstream pathways including JAK-STAT, MAPK, and PI3K signaling.

JAK-STAT Signaling

Leptin binding to OB-R activates JAK2 kinase, which phosphorylates STAT3 and STAT5. These transcription factors translocate to the nucleus and regulate genes involved in appetite suppression (POMC neurons) and energy expenditure.

MAPK/ERK Pathway

Leptin activates extracellular signal-regulated kinase (ERK) signaling, contributing to metabolic effects and gene expression changes in hypothalamic neurons controlling feeding behavior.

PI3K/Akt Pathway

Phosphatidylinositol 3-kinase activation by leptin signaling promotes glucose uptake and metabolic substrate utilization in peripheral tissues and the central nervous system.

Hypothalamic AMPK Inhibition

Leptin suppresses AMP-activated protein kinase (AMPK) in the hypothalamus, reducing appetite-stimulating neuropeptide Y (NPY) and agouti-related peptide (AgRP) expression.

Immune Regulation

Leptin receptors on T cells and macrophages modulate immune responses, promoting Th1 differentiation and pro-inflammatory cytokine production; leptin deficiency impairs cell-mediated immunity.

  • Leptin is a 167-amino-acid peptide hormone with a molecular weight of approximately 16 kDa
  • Circulating leptin levels are proportional to total body fat mass and correlate with energy stores
  • Leptin resistance — reduced hypothalamic sensitivity to leptin despite elevated circulating levels — is common in obesity and metabolic syndrome
  • Leptin replacement is effective only in congenital leptin deficiency (rare genetic mutation) or acquired lipodystrophy; efficacy is limited in common obesity due to leptin resistance
  • Leptin has circadian rhythm variation, with peak levels typically occurring in the evening and early night
  • Leptin interacts with other metabolic hormones including insulin, ghrelin, and thyroid hormones to coordinate energy homeostasis

Track your Leptin research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Leptin is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.